Dietary Factors Modulate Helicobacter-associated Gastric Cancer in Rodent Models

Since its discovery in 1982, the global importance of Helicobacter pylori-induced disease, particularly in developing countries, remains high. The use of rodent models, particularly mice, and the unanticipated usefulness of the gerbil to study H. pylori pathogenesis have been used extensively to stu...

Full description

Bibliographic Details
Main Authors: Fox, James G. (Contributor), Wang, Timothy C. (Author)
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. Division of Comparative Medicine (Contributor)
Format: Article
Language:English
Published: Sage Publications, 2015-10-20T12:41:07Z.
Subjects:
Online Access:Get fulltext
LEADER 01678 am a22002293u 4500
001 99368
042 |a dc 
100 1 0 |a Fox, James G.  |e author 
100 1 0 |a Massachusetts Institute of Technology. Department of Biological Engineering  |e contributor 
100 1 0 |a Massachusetts Institute of Technology. Division of Comparative Medicine  |e contributor 
100 1 0 |a Fox, James G.  |e contributor 
700 1 0 |a Wang, Timothy C.  |e author 
245 0 0 |a Dietary Factors Modulate Helicobacter-associated Gastric Cancer in Rodent Models 
260 |b Sage Publications,   |c 2015-10-20T12:41:07Z. 
856 |z Get fulltext  |u http://hdl.handle.net/1721.1/99368 
520 |a Since its discovery in 1982, the global importance of Helicobacter pylori-induced disease, particularly in developing countries, remains high. The use of rodent models, particularly mice, and the unanticipated usefulness of the gerbil to study H. pylori pathogenesis have been used extensively to study the interactions of the host, the pathogen, and the environmental conditions influencing the outcome of persistent H. pylori infection. Dietary factors in humans are increasingly recognized as being important factors in modulating progression and severity of H. pylori-induced gastric cancer. Studies using rodent models to verify and help explain mechanisms whereby various dietary ingredients impact disease outcome should continue to be extremely productive. 
520 |a National Institutes of Health (U.S.) (P01CA028842) 
520 |a National Institutes of Health (U.S.) (P01CA026731) 
520 |a National Institutes of Health (U.S.) (P30ES002109) 
546 |a en_US 
655 7 |a Article 
773 |t Toxicologic Pathology